Impact of combination therapy with repeat surgery and temozolomide for recurrent or progressive glioblastoma multiforme: a prospective trial

Surgical Neurology

Volumn 68, Issue 3, 2007, Pages 250-254

  Terasaki, Mizuhiko ^a   Ogo, Etsuyo ^a   Fukushima, Shintaro ^a   Sakata, Kiyohiko ^a   Miyagi, Naohisa ^a   Abe, Toshi ^a   Shigemori, Minoru ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glioblastoma; Repeat surgery; Survival; Temozolomide

Indexed keywords

CEPHARANTHINE; NIMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; CALCULATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; FEASIBILITY STUDY; FEMALE; GLIOBLASTOMA; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROSURGERY; NEUTROPENIA; OVERALL SURVIVAL; REOPERATION; RISK ASSESSMENT; STATISTICAL ANALYSIS; STOMATITIS; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TIME SERIES ANALYSIS; TUMOR LOCALIZATION; VOMITING;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DACARBAZINE; FEASIBILITY STUDIES; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; REOPERATION; RETROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34548023940     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2006.11.042     Document Type: Article

References (20)

1. Brada M., Hoang-Xuan K., Rampling R., Dietrich P.Y., Dirix L.Y., Macdonald D., Heimans J.J., Zonnenberg B.A., Bravo-Marques J.M., Henriksson R., Stupp R., Yue N., Bruner J., Dugan M., Rao S., and Zaknoen S. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol 12 (2001) 259-266
2. Burger P.C., and Green S.B. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 59 (1987) 1617-1625
3. Burger P.C., Vogel F.S., Green S.B., and Strike T.A. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56 (1985) 1106-1111
4. Busy P.C. Glioblastomas. Surg Neurol 24 (1985) 589-590
5. Estlin E.J., Lashford L., Ablett S., Price L., Gowing R., Gholkar A., Kohler J., Lewis I.J., Morland B., Pinkerton C.R., Stevens M.C., Mott M., Stevens R., Newell D.R., Walker D., McDowell H., Reidenberg P., Statkevich P., Marco A., Batra V., Dugan M., and Pearson A.D. Phase 1 study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group. Br J Cancer 78 (1998) 652-661
6. Gilbert M.R., Friedman H.S., Kuttesch J.F., Prados M.D., Olson J.J., Reaman G.H., and Zaknoen S.L. A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy. Neurooncology 4 (2002) 261-267
7. Gonzalez J., and Gilbert M.R. Treatment of astrocytoma. Curr Opin Neurol 18 (2005) 632-638
8. Guyotat J., Signorelli F., Frappaz D., Madarassy G., Ricci A.C., and Bret P. Is reoperation for recurrence of glioblastoma justified?. Oncol Rep 7 (2000) 899-904
9. Hegi M.E., and Stupp R. Correlative studies in neuro-oncology trials: should they influence treatment?. Curr Oncol Rep 8 (2006) 54-57
10. Heppner F. The glioblastoma multiforme: a lifelong challenge to the neurosurgeon. Neurochirurgia 29 (1986) 9-14
11. Hsieh P.C., Chandler J.P., Bhangoo S., Panagiotopoulos K., Kalapurakal J.A., Marymont M.H., Cozzens J.W., Levy R.M., and Salehi S. Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme. Neurosurgery 57 (2005) 684-692
12. Kohshi K., Kinoshita Y., Terashima H., Konda N., Yokota A., and Soejima T. Radiotherapy after hyperbaric oxygenation for malignant gliomas: a pilot study. J Cancer Res Clin Oncol 122 (1996) 676-678
13. Nicholson H.S., Krailo M., Ames M.M., Seibel N.L., Reid J.M., Liu-Mares W., Vezina L.G., Ettinger A.G., and Reaman G.H. Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer Group. J Clin Oncol 16 (1998) 3037-3043
14. Ogawa K., Yoshii Y., Inoue O., Toita T., Saito A., Kakinohana Y., Adachi G., Ishikawa Y., Kin S., and Murayama S. Prospective trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas. Radiother Oncol 67 (2003) 63-67
15. Ransohoff J., and Lieberman A. Surgical therapy of primary malignant brain tumors. Clin Neurosurg 25 (1978) 403-411
16. Salcman M. Survival in glioblastoma: historical perspective. Neurosurgery 7 (1980) 435-439
17. Stupp R., Hegi M.E., van den Bent M.J., Mason W.P., Weller M., Mirimanoff R.O., Cairncross J.G., European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, and National Cancer Institute of Canada Clinical Trials Group. Changing paradigms-an update on the multidisciplinary management of malignant glioma. Oncologist 11 (2006) 165-180
18. Stupp R., van den Bent M.J., and Hegi M.E. Optimal role of temozolomide in the treatment of malignant gliomas. Curr Neurol Neurosci Rep 5 (2005) 198-206
19. Taveras J.M., Thompson Jr. H.G., and Pool J.L. Should we treat glioblastoma multiforme?. AJNR Am J Neuroradiol 87 (1962) 473-479
20. Yung W.K., Albright R.E., Olson J., Fredericks R., Fink K., Prados M.D., Brada M., Spence A., Hohl R.J., Shapiro W., Glantz M., Greenberg H., Selker R.G., Vick N.A., Rampling R., Friedman H., Phillips P., Bruner J., Yue N., Osoba D., Zaknoen S., and Levin V.A. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83 (2000) 588-593